Why the study?
Does tobacco smoking increase the risk of a broad spectrum of cardiovascular diseases including heart failure, atrial fibrillation, and venous thromboembolism?
Does tobacco smoking increase the risk of a broad spectrum of cardiovascular diseases including heart failure, atrial fibrillation, and venous thromboembolism?
Tobacco smoking, including heat-not-burn alternatives, continues to be a major risk factor for a broad spectrum of cardiovascular diseases, necessitating ongoing physician vigilance.
Answers are grounded in this paper and cite their sources.
Maintain smoking cessation efforts in Japan; extends observational CVD links but leaves causal estimates open.
Tobacco smoking continues to be a major risk factor for cardiovascular disease (CVD) and the leading avoidable cause of death worldwide. Tobacco smoking has declined in high-income countries, but the average smoking rate in Japan remains high: 29.4% for men and 7.2% for women in 2017. Of note, the average smoking rate among middle-aged men remains approximately 40%, indicating that a high incidence of smoking-related CVD will continue for a couple of decades in Japan. The adverse effects of tobacco smoking on CVD are more extensive than previously thought. Physicians should be particularly alert to the development and progression of heart failure, atrial fibrillation, and venous thromboembolism, as well as ischemic CVD among tobacco smokers. Increasing use of heat-not-burn tobacco as cigarette alternatives is an emerging issue. Harmful effects do not disappear just by changing the delivery system of tobacco.
No takes yet. Share an insight, caveat, or question.
Kondo et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: